| Company Name: | America Service Group | | Ticker Symbol: | ASGR | | | WWW Address: | www.asgr.com |
| CEO: | | | No. of Employees: | 3,290 |
| Common Issue Type: | CS | | Business Description: | American Service Group Inc. through its subsidiaries provides or administers healthcare services to over 160 correctional facilities throughout the U.S. It is also a non-governmental provider and/or administrator of correctional healthcare services.
|
| | | Industry Information: | HEALTH SERVICES - Specialized Health Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 26.01 |  0.0 | - | - | | 26.01 | 26.01 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 241.8 | 9.3 | 0.78 | 1.05 | 0.24 | 29.6 | 0.9 | 26.10 - 12.84 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 26.01 | $ | | PE Ratio - LTM | 29.6 | |
| Market Capitalisation | 241.8 | mil |
| Latest Shares Outstanding | 9.3 | mil |
| Earnings pS (EPS) | 1.05 | $ |
| Dividend pS (DPS) | 0.24 | ¢ |
| Dividend Yield | 0.9 | % |
| Dividend Payout Ratio | 23 | % |
| Revenue per Employee | 191,581 | $ |
| Effective Tax Rate | 43.9 | % |
| Float | 9.0 | mil |
| Float as % of Shares Outstanding | 97.0 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 5.20 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 8.6 | % |
| EBITDA Margin | 3.4 | % |
| Pre-Tax Profit Margin | 2.5 | % |
| Assets Turnover | 3.5 | % |
| Return on Assets (ROA) | 4.6 | % |
| Return on Equity (ROE) | 14.1 | % |
| Return on Capital Invested (ROCI) | 14.1 | % |
| Current Ratio | 1.1 | |
| Leverage Ratio (Assets/Equity) | 3.1 | |
| Interest Cover | 274.7 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 1.37 | $ |
| Cash pS | 4.47 | $ |
| Book-Value pS | 6.18 | $ |
| Tangible Book-Value pS | 1.80 | $ |
| Cash Flow pS | 1.26 | $ |
| Free Cash Flow pS | 0.05 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 4.21 | |
| Price/Tangible Book Ratio | 14.45 | |
| Price/Cash Flow | 20.7 | |
| Price/Free Cash Flow | 498.6 | |
| P/E as % of Industry Group | 172.0 | % |
| P/E as % of Sector Segment | 156.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Cash Payment |
| Dividend Rate | 0.24 |
| Current Dividend Yield | 0.9 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 23.0 |
| 5-Y Average Payout Ratio | 10.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.0 | 101 | 385 | |
| 4 Weeks | 26.01 | 25.87 | 25.89 | 0.5 | 105 | 503 | 9,560 |
| 13 Weeks | 26.01 | 25.57 | 25.72 | 1.1 | 103 | 817 | 51,475 |
| 26 Weeks | 26.10 | 14.37 | 14.47 | 79.8 | 174 | 932 | 116,540 |
| 52 Weeks | 26.10 | 12.84 | 16.55 | 57.2 | 134 | 673 | 169,640 |
| YTD | 26.10 | 14.94 | - | 71.8 | 168 | 1,014 | 112,570 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 26.01 | 26.00 | 25.85 | 20.75 | 19.13 | 0.78 | 0.69 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 1.59 | 7.5 | 9.55 |
| Income | 0.00 | 0.0 | 42.79 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 11.21 | NA | 29.00 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -5.3 | -5.3 | 4.0 |
| Earnings % | -45.0 | -45.0 | 191.0 |
| EPS % | -45.7 | -45.7 | 200.0 |
| EPS $ | -0.16 | -0.16 | 0.70 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 8.87 |
| Current Ratio | 1.2 |
| Quick Ratio (Acid Test) | 1.0 |
| Liquidity Ratio (Cash) | 0.41 |
| Receivables Turnover | 13.0 |
| Average Collection Period | 28 |
| Working Capital/Equity | 28.2 |
| Working Capital pS | 1.70 |
| Cash-Flow pS | 1.39 |
| Free Cash-Flow pS | 0.23 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 5.32 |
| Financial Leverage Ratio (Assets/Equity) | 3.2 |
| Debt Ratio | 68.6 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 45.4 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 232.6 |
| Interest/Capital Invested | 0.09 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 3.99 |
| Tobin's Q Ratio | 1.36 |
| Current P/E Ratio - LTM | 29.60 |
| Enterprise Value (EV)/EBITDA | 14.68 |
| Enterprise Value (EV)/Free Cash Flow | 387.05 |
| Dividend Yield | 0.9 |
| Price/Tangible Book Ratio - LTM | 14.45 |
| Price/Book Ratio - LTM | 4.21 |
| Price/Cash Flow Ratio | 20.7 |
| Price/Free Cash Flow Ratio - LTM | 498.6 |
| Price/Sales Ratio | 0.39 |
| P/E Ratio (1 month ago) - LTM | 29.4 |
| P/E Ratio (26 weeks ago) - LTM | 17.4 |
| P/E Ratio (52 weeks ago) - LTM | 26.7 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 172.0 |
| P/E as % of Sector Segment | 156.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 23.5 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 10.38 |
| Tangible Book Value pS - LTM | 1.80 |
| Book Value pS - LTM | 6.18 |
| Capital Invested pS | 6.00 |
| Cash pS - LTM | 4.47 |
| Cash Flow pS - LTM | 1.26 |
| Free Cash Flow pS - LTM | 0.05 |
| Earnings pS (EPS) | 1.05 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 0.34 |
| Free Cash Flow Margin 5YEAR AVG | 2.80 |
| Net Profit Margin | 1.5 |
| Net Profit Margin - 5YEAR AVRG. | 0.6 |
| Equity Productivity | 11.30 |
| Return on Equity (ROE) | 17.1 |
| Return on Equity (ROE) - 5YEAR AVRG. | 7.1 |
| Capital Invested Productivity | 11.30 |
| Return on Capital Invested (ROCI) | 17.1 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 7.1 |
| Assets Productivity | 3.60 |
| Return on Assets (ROA) | 5.4 |
| Return on Assets (ROA) - 5YEAR AVRG. | 1.9 |
| Gross Profit Margin | 8.6 |
| Gross Profit Margin - 5YEAR AVRG. | 7.6 |
| EBITDA Margin - LTM | 3.4 |
| EBIT Margin - LTM | 2.5 |
| Pre-Tax Profit Margin | 2.8 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 1.0 |
| Effective Tax Rate | 43.9 |
| Effective Tax Rate - 5YEAR AVRG. | -0.8 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 32 |
| Revenue per Employee | 191,581 |
| Net Income per Employee | 2,902 |
| Average Collection Period | 30 |
| Receivables Turnover | 13.0 |
| Day's Inventory Turnover Ratio | 2 |
| Inventory Turnover | 198.6 |
| Inventory/Sales | 0.5 |
| Accounts Payble/Sales | 3.76 |
| Assets/Revenue | 0.28 |
| Net Working Capital Turnover | 40.05 |
| Fixed Assets Turnover | 9.65 |
| Total Assets Turnover | 3.6 |
| Revenue per $ Cash | 15.92 |
| Revenue per $ Plant | 57.09 |
| Revenue per $ Common Equity | 11.30 |
| Revenue per $ Capital Invested | 11.30 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 5.2 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 5.6 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
